Potassium Chloride Extended Release Tablets

Contract SPE2D2-26-D-0001 is an award issued by DLA Troop Support to AvKARE, LLC for the procurement of Potassium Chloride Extended Release tablets. The contract is valued at an estimated $39,510,148.75 over a five-year period, consisting of a base year and four option years. The scope of work includes the delivery of 10 MEQ and 20 MEQ tablets in both 100 and 500 count bottles. Manufacturing is split between facilities in Maple Grove, Minnesota, and Zhunan Township, Taiwan, with packaging and shipment preparation handled by APACE Packaging, LLC and R&S Northeast, LLC in Fountain Run, Kentucky. The award was based on a reverse auction conducted on July 29, 2025, following solicitation SPE2D2-24-R-0013 and nine subsequent amendments. The contract mandates strict adherence to various FAR and DFARS regulations, with significant emphasis on cybersecurity standards including NIST SP 800-171 and CMMC requirements. Additional compliance measures include the Federal Acquisition Supply Chain Security Act, Buy American provisions, and various labor and ethics standards. Delivery logistics are governed by Department of Defense marking standards, specifically referencing Item Unique Identification and Valuation.